Cargando…
Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1
Dengue virus (DENV) is a major global health problem, with over half of the world’s population at risk of infection. Despite over 60 years of efforts, no licensed vaccine suitable for population-based immunization against DENV is available. Here, we describe efforts to engineer epitope-based vaccine...
Autores principales: | Warner, Nikole L., Frietze, Kathryn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310087/ https://www.ncbi.nlm.nih.gov/pubmed/34358143 http://dx.doi.org/10.3390/vaccines9070726 |
Ejemplares similares
-
Unbiased Identification of Dengue Virus Non-Structural Protein 1 Peptides for Use in Vaccine Design
por: Warner, Nikole L., et al.
Publicado: (2022) -
Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display
por: Crossey, Erin, et al.
Publicado: (2015) -
Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
por: Shen, Wen-Fan, et al.
Publicado: (2018) -
Display of single-chain variable fragments on bacteriophage MS2 virus-like particles
por: Lino, Christopher A., et al.
Publicado: (2017) -
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition
por: Menzies, Stefanie K., et al.
Publicado: (2022)